Real-world ambrisentan safety profile as expected

Analysis of the VOLibris Tracking post-marketing registry shows no new safety issues for ambrisentan used in patients with pulmonary arterial hypertension.
Source: MedWire News - Category: Consumer Health News Tags: Pulmonary hypertension Source Type: news